Cancer Communications: Impact Factor, Indexing, Publication Time & Fees


The Cancer Communications is reputed journal publishes research related to Cancer Research (Q1); Oncology (Q1). The ISSN of the journal is .

Through this web page, researchers can check the indexing, publication fee, journal quartile, and journal aim & scope.

Cancer Communications: Details

Journal TitleCancer Communications
PublisherJohn Wiley & Sons Inc.
Publication CountryUnited Kingdom
ISSN25233548
Publication AreaBiochemistry, Genetics and Molecular Biology; Medicine
Publication Language
Review ProcessAnonymous peer review
Scopus IndexedYes

Cancer Communications Impact Factor

The Impact Factor of Cancer Communications in 2026 is 28.4.

Journal Quartile

The Cancer Communications is ranked in Q1.

Indexing

The Cancer Communications is indexed in: DOAJ, Web of Science.

Publication Fee

There is a fee to publish in the Cancer Communications. The publication fee is 2800 USD; 2100 GBP; 2400 EUR.

The journal also offers a fee waiver policy.

Publication Time

The Cancer Communications takes an average of 4 weeks to publish research papers.

Journal Official Website

The official website of the journal is https://onlinelibrary.wiley.com/journal/25233548.

Please visit only official website of the journal to submit research papers.



Similiar journals to publish


Bulletin du cancer. Radiotherapie : journal de la Societe francaise du cancer : organe de la societe francaise de radiotherapie oncologique
ISSN: 9244212
Publisher: Elsevier B.V.
Journal Scope:

International journal of cancer. Supplement = Journal international du cancer. Supplement
ISSN: 8986924
Publisher: John Wiley & Sons Inc.
Journal Scope:

Cancer Communications
ISSN:
Publisher: John Wiley & Sons Inc.
Journal Scope: Cancer Research (Q1); Oncology (Q1)

Cancer Research Communications
ISSN:
Publisher: American Association for Cancer Research Inc.
Journal Scope: Cancer Research (Q1); Oncology (Q1)

Cancer Treatment and Research Communications
ISSN:
Publisher: Elsevier Ltd
Journal Scope: Cancer Research (Q2); Oncology (Q2)

Cancer Communications
ISSN: 9553541
Publisher: Pergamon Press Ltd.
Journal Scope: